Molecular characterization of non-small cell lung cancer tumors in Latin American patients from Brazil, Chile and Peru uncovers novel potentially driver mutations
Introduction Therapies that target activating Egfr, Alk, Ros1 and other mutations have become
first-line treatments that improve NSCLC patient’s life expectancy. Latin-American patients …
first-line treatments that improve NSCLC patient’s life expectancy. Latin-American patients …